Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Krabeva 400 mg Injection
Manufacturer/Marketed By : Biocon Biologics India Ltd
$405.45 $325.29
Krabeva 400 mg injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative treatment...
Bevacizumab 400 mg
Active Pharmaceutical Ingredient
Krabeva 400 mg Injection
$405.45
$325.29
Krabeva 400 mg injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative treatment contains Bevacizumab, a monoclonal antibody that effectively inhibits vascular endothelial growth factor (VEGF), a protein that plays a crucial role in tumor growth and blood vessel formation. By blocking VEGF, Krabeva helps to restrict the blood supply to tumors, thereby slowing their progression and enhancing the efficacy of other cancer treatments. It is essential to discuss potential side effects with your healthcare provider, as Krabeva may lead to serious conditions like high blood pressure or bleeding complications. As with any chemotherapy regimen, monitoring during treatment is vital to ensure patient safety and treatment effectiveness. Krabeva 400 mg is typically administered in conjunction with other anticancer medications, tailoring the therapy to individual patient needs. For those battling cancer, Krabeva represents a vital option in the fight against this challenging disease, offering hope for improved outcomes. Always consult your oncologist to determine if Krabeva is the right choice for your treatment plan.
Active Pharmaceutical Ingredient
Uses
• Krabeva 400 mg injection is indicated for the treatment of colorectal cancer, which affects the colon and rectum. Patients may experience symptoms like changes in bowel habits, including diarrhea or constipation. The injection helps manage these symptoms and targets the cancerous cells in the large intestine. This approach aims to improve the overall quality of life for individuals diagnosed with this condition.
• In cases of non-small cell lung cancer, Krabeva 400 mg injection plays a crucial role in the therapeutic regimen. This type of lung cancer can lead to persistent coughing, chest discomfort, and shortness of breath. The medication works to inhibit the growth of cancer cells, helping to alleviate some of the distressing symptoms associated with the disease. Patients often report an improvement in their respiratory function and overall well-being.
• Krabeva 400 mg injection is also utilized in the treatment of glioblastoma, a highly aggressive form of brain cancer. Symptoms such as severe headaches, cognitive impairment, and seizures may be present in affected individuals. By targeting the glial cells, the injection aims to slow down tumor progression and provide symptomatic relief. This is particularly vital for enhancing the patient's cognitive function and quality of life.
• Additionally, Krabeva 400 mg injection is effective in managing kidney cancer, which arises in the cells lining the kidney's filtration tubes. Patients with this type of cancer may experience symptoms like blood in the urine and back pain. The injection helps to target and reduce the cancerous growth, potentially leading to improved kidney function and symptom relief. This treatment is important for patients seeking to manage their condition effectively.
Benefits
Krabeva 400 mg Injection can help to slow or stop the growth of cancer cells, which may lead to a reduction in the size of tumors or the spread of cancer to other parts of the body. Krabeva 400 mg/16 ml Vial may help to reduce the risk of cancer progressing, which may improve the chances of successful long-term treatment outcomes. In some studies, Krabeva 400 mg has been shown to improve survival rates in people with certain types of cancer, including colorectal, ovarian, and lung cancer.
Side Effects
Like all medications, Krabeva Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Body Weakness
• Constipation
• Loss of Appetite
• Speech Change
• Nausea
• Diarrhoea
Common Side Effects
• Allergic Reactions
• Delay in Wound Healing
• Change in Vision
• Headache
• High Blood Pressure
How To Use
Krabeva 400 mg Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Krabeva 400 mg will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this Krabeva 400 mg/16 ml Vial.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Anti-cancer Injection Krabeva. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Anti-cancer Injection Krabeva and report any unusual symptoms or changes in kidney function to their physician. The dose of Krabeva Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Krabeva Injection. Krabeva 400 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Bevacizumab 400 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Bevacizumab 400 mg Injection if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Krabeva 400 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Injection Krabeva during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Krabeva 400 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Krabeva 400 mg/16 ml Vial.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.